| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MRF binding | 6.76e-05 | 6 | 43 | 2 | GO:0043426 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.59e-04 | 127 | 43 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | cAMP response element binding | 2.95e-04 | 12 | 43 | 2 | GO:0035497 | |
| GeneOntologyMolecularFunction | cAMP response element binding protein binding | 2.95e-04 | 12 | 43 | 2 | GO:0008140 | |
| GeneOntologyMolecularFunction | leucine zipper domain binding | 4.05e-04 | 14 | 43 | 2 | GO:0043522 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | BPTF CHD7 USF3 HIVEP1 CDC5L ATF2 ZNF251 CREBBP CREB5 ZNF280C | 8.68e-04 | 1459 | 43 | 10 | GO:0000977 |
| GeneOntologyMolecularFunction | LRR domain binding | 1.02e-03 | 22 | 43 | 2 | GO:0030275 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | 7.22e-06 | 700 | 36 | 10 | MP:0011098 | |
| MousePheno | embryonic lethality during organogenesis | MAP3K20 BPTF TAB2 CHD7 POGZ EP400 WNK1 MAP4K4 CREBBP CIAO3 UBR4 | 7.74e-06 | 876 | 36 | 11 | MP:0006207 |
| MousePheno | stereotypic behavior | 1.59e-05 | 214 | 36 | 6 | MP:0001408 | |
| MousePheno | atrioventricular cushion hypoplasia | 9.61e-05 | 6 | 36 | 2 | MP:0030992 | |
| MousePheno | abnormal head movements | 1.37e-04 | 103 | 36 | 4 | MP:0000436 | |
| Domain | TF_CRE-BP1-typ | 1.48e-05 | 3 | 42 | 2 | IPR016378 | |
| Domain | SANT | 1.93e-04 | 50 | 42 | 3 | SM00717 | |
| Domain | SANT/Myb | 2.16e-04 | 52 | 42 | 3 | IPR001005 | |
| Domain | SAM | 1.35e-03 | 97 | 42 | 3 | IPR001660 | |
| Domain | Bromodomain_CS | 1.55e-03 | 26 | 42 | 2 | IPR018359 | |
| Domain | ZINC_FINGER_C2H2_2 | 1.56e-03 | 775 | 42 | 7 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 1.59e-03 | 777 | 42 | 7 | PS00028 | |
| Domain | - | 1.74e-03 | 106 | 42 | 3 | 1.10.150.50 | |
| Domain | Znf_C2H2-like | 1.82e-03 | 796 | 42 | 7 | IPR015880 | |
| Domain | Znf_C2H2 | 1.94e-03 | 805 | 42 | 7 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.98e-03 | 808 | 42 | 7 | SM00355 | |
| Domain | SAM/pointed | 2.30e-03 | 117 | 42 | 3 | IPR013761 | |
| Domain | SNF2_N | 2.35e-03 | 32 | 42 | 2 | PF00176 | |
| Domain | SNF2_N | 2.35e-03 | 32 | 42 | 2 | IPR000330 | |
| Domain | bZIP_1 | 2.65e-03 | 34 | 42 | 2 | PF00170 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.80e-03 | 35 | 42 | 2 | IPR002464 | |
| Domain | TF_DNA-bd | 3.13e-03 | 37 | 42 | 2 | IPR008917 | |
| Domain | BROMODOMAIN_1 | 3.13e-03 | 37 | 42 | 2 | PS00633 | |
| Domain | DEAH_ATP_HELICASE | 3.30e-03 | 38 | 42 | 2 | PS00690 | |
| Domain | MYB_LIKE | 3.30e-03 | 38 | 42 | 2 | PS50090 | |
| Domain | Bromodomain | 3.30e-03 | 38 | 42 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 3.83e-03 | 41 | 42 | 2 | PS50014 | |
| Domain | BROMO | 4.02e-03 | 42 | 42 | 2 | SM00297 | |
| Domain | Bromodomain | 4.02e-03 | 42 | 42 | 2 | IPR001487 | |
| Domain | - | 4.02e-03 | 42 | 42 | 2 | 1.20.920.10 | |
| Domain | BRLZ | 6.10e-03 | 52 | 42 | 2 | SM00338 | |
| Domain | BZIP | 6.33e-03 | 53 | 42 | 2 | PS50217 | |
| Domain | BZIP_BASIC | 6.33e-03 | 53 | 42 | 2 | PS00036 | |
| Domain | bZIP | 6.56e-03 | 54 | 42 | 2 | IPR004827 | |
| Domain | Kinase-like_dom | 7.09e-03 | 542 | 42 | 5 | IPR011009 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION | 2.21e-06 | 13 | 29 | 3 | M47595 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TNF_P38_SIGNALING_PATHWAY | 1.54e-05 | 24 | 29 | 3 | M47568 | |
| Pathway | BIOCARTA_PCAF_PATHWAY | 1.46e-04 | 9 | 29 | 2 | MM1533 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 2.44e-04 | 151 | 29 | 4 | M39801 | |
| Pathway | WP_MAPK_SIGNALING_PATHWAY | 3.04e-04 | 160 | 29 | 4 | MM15990 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_CREB_MEDIATED_TRANSCRIPTION | 3.14e-04 | 13 | 29 | 2 | M47674 | |
| Pathway | BIOCARTA_PCAF_PATHWAY | 3.14e-04 | 13 | 29 | 2 | M22007 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY | 4.82e-04 | 16 | 29 | 2 | M47551 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKACA_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 5.45e-04 | 17 | 29 | 2 | M47514 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKAR1A_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 6.13e-04 | 18 | 29 | 2 | M47516 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PDE11A_PDE8B_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 7.59e-04 | 20 | 29 | 2 | M47517 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY | 8.38e-04 | 21 | 29 | 2 | M47792 | |
| Pathway | KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY | 1.01e-03 | 23 | 29 | 2 | M47799 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.01e-03 | 23 | 29 | 2 | M47512 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.10e-03 | 24 | 29 | 2 | M47520 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.10e-03 | 24 | 29 | 2 | M47509 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.19e-03 | 25 | 29 | 2 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.19e-03 | 25 | 29 | 2 | M47511 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.29e-03 | 26 | 29 | 2 | M47553 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.39e-03 | 27 | 29 | 2 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.39e-03 | 27 | 29 | 2 | M47519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 1.49e-03 | 28 | 29 | 2 | M47647 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.49e-03 | 28 | 29 | 2 | M47508 | |
| Pathway | WP_MAPK_SIGNALING | 1.52e-03 | 246 | 29 | 4 | M39597 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRNP_PI3K_NOX2_SIGNALING_PATHWAY | 1.60e-03 | 29 | 29 | 2 | M47764 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.60e-03 | 29 | 29 | 2 | M47515 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 1.60e-03 | 29 | 29 | 2 | M47627 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.83e-03 | 31 | 29 | 2 | M47507 | |
| Pathway | PID_WNT_NONCANONICAL_PATHWAY | 1.95e-03 | 32 | 29 | 2 | M23 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.95e-03 | 32 | 29 | 2 | M47506 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 2.06e-03 | 267 | 29 | 4 | M10792 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY | 2.07e-03 | 33 | 29 | 2 | M47550 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.20e-03 | 272 | 29 | 4 | M29619 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 2.60e-03 | 37 | 29 | 2 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 2.60e-03 | 37 | 29 | 2 | MM15610 | |
| Pubmed | 2.47e-08 | 549 | 44 | 9 | 38280479 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 3.59e-08 | 150 | 44 | 6 | 28242625 | |
| Pubmed | 1.57e-07 | 486 | 44 | 8 | 20936779 | ||
| Pubmed | 3.94e-07 | 225 | 44 | 6 | 12168954 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 4.51e-07 | 774 | 44 | 9 | 15302935 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 6.06e-07 | 394 | 44 | 7 | 27248496 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAP3K20 DYNC1LI1 CHD7 POGZ DST CDC5L GTF3C1 EP400 CREBBP PDLIM7 UBR4 | 6.97e-07 | 1353 | 44 | 11 | 29467282 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 7.73e-07 | 1082 | 44 | 10 | 38697112 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.09e-06 | 861 | 44 | 9 | 36931259 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 37816820 | ||
| Pubmed | 3.40e-06 | 733 | 44 | 8 | 34672954 | ||
| Pubmed | 3.81e-06 | 83 | 44 | 4 | 28794006 | ||
| Pubmed | LAF4 maps to mouse chromosome 1 and human chromosome 2q11.2-q12. | 4.69e-06 | 3 | 44 | 2 | 8662235 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 9590171 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 19948881 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.17e-06 | 351 | 44 | 6 | 38297188 | |
| Pubmed | 5.98e-06 | 360 | 44 | 6 | 33111431 | ||
| Pubmed | 8.20e-06 | 1103 | 44 | 9 | 34189442 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 8.49e-06 | 588 | 44 | 7 | 38580884 | |
| Pubmed | CBP alleviates the intramolecular inhibition of ATF-2 function. | 9.37e-06 | 4 | 44 | 2 | 9786917 | |
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 15735738 | ||
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 16303757 | ||
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 8440710 | ||
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 9194565 | ||
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 11564156 | ||
| Pubmed | 1.03e-05 | 396 | 44 | 6 | 26687479 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.05e-05 | 608 | 44 | 7 | 36089195 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.06e-05 | 398 | 44 | 6 | 35016035 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 1.06e-05 | 857 | 44 | 8 | 25609649 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 1.27e-05 | 411 | 44 | 6 | 35182466 | |
| Pubmed | 1.40e-05 | 418 | 44 | 6 | 34709266 | ||
| Pubmed | 1.44e-05 | 638 | 44 | 7 | 31182584 | ||
| Pubmed | 1.56e-05 | 5 | 44 | 2 | 9659924 | ||
| Pubmed | 1.56e-05 | 5 | 44 | 2 | 17296604 | ||
| Pubmed | NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler. | 1.56e-05 | 5 | 44 | 2 | 26626481 | |
| Pubmed | 1.56e-05 | 5 | 44 | 2 | 17500068 | ||
| Pubmed | 1.56e-05 | 5 | 44 | 2 | 19576892 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.64e-05 | 430 | 44 | 6 | 35044719 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 1.93e-05 | 125 | 44 | 4 | 32891193 | |
| Pubmed | 2.22e-05 | 268 | 44 | 5 | 33640491 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.30e-05 | 954 | 44 | 8 | 36373674 | |
| Pubmed | Ubiquitin plays an atypical role in GPCR-induced p38 MAP kinase activation on endosomes. | 2.34e-05 | 6 | 44 | 2 | 26391660 | |
| Pubmed | 2.34e-05 | 6 | 44 | 2 | 10327051 | ||
| Pubmed | 2.34e-05 | 6 | 44 | 2 | 16446357 | ||
| Pubmed | 2.34e-05 | 6 | 44 | 2 | 31964530 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 2.91e-05 | 1294 | 44 | 9 | 30804502 | |
| Pubmed | 3.27e-05 | 7 | 44 | 2 | 38383842 | ||
| Pubmed | 3.27e-05 | 7 | 44 | 2 | 17626013 | ||
| Pubmed | 3.27e-05 | 7 | 44 | 2 | 7774816 | ||
| Pubmed | CHD7, the gene mutated in CHARGE syndrome, regulates genes involved in neural crest cell guidance. | 3.27e-05 | 7 | 44 | 2 | 24728844 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.55e-05 | 146 | 44 | 4 | 23892456 | |
| Pubmed | 3.68e-05 | 497 | 44 | 6 | 23414517 | ||
| Pubmed | 4.26e-05 | 153 | 44 | 4 | 10718198 | ||
| Pubmed | Regulation of a mitogen-activated protein kinase kinase kinase, MLTK by PKN. | 4.36e-05 | 8 | 44 | 2 | 12761180 | |
| Pubmed | Casein kinase II interacts with the bZIP domains of several transcription factors. | 4.36e-05 | 8 | 44 | 2 | 9685505 | |
| Pubmed | 4.71e-05 | 157 | 44 | 4 | 30186101 | ||
| Pubmed | 5.20e-05 | 529 | 44 | 6 | 14621295 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DYNC1LI1 POGZ HIVEP1 CDC5L GTF3C1 MAP4K4 VPS13C UBR4 ZNF280C | 6.15e-05 | 1425 | 44 | 9 | 30948266 |
| Pubmed | 6.28e-05 | 1429 | 44 | 9 | 35140242 | ||
| Pubmed | 6.45e-05 | 808 | 44 | 7 | 20412781 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 6.98e-05 | 341 | 44 | 5 | 32971831 | |
| Pubmed | 6.99e-05 | 10 | 44 | 2 | 18087039 | ||
| Pubmed | 6.99e-05 | 10 | 44 | 2 | 34732824 | ||
| Pubmed | 8.54e-05 | 11 | 44 | 2 | 9162092 | ||
| Pubmed | Expression QTL and regulatory network analysis of microtubule-associated protein tau gene. | 8.54e-05 | 11 | 44 | 2 | 19233709 | |
| Pubmed | 8.54e-05 | 11 | 44 | 2 | 10066798 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 8.89e-05 | 583 | 44 | 6 | 29844126 | |
| Pubmed | 9.57e-05 | 591 | 44 | 6 | 15231748 | ||
| Pubmed | Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor. | 1.02e-04 | 12 | 44 | 2 | 12748276 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 1.02e-04 | 370 | 44 | 5 | 22922362 | |
| Pubmed | 1.35e-04 | 78 | 44 | 3 | 17192257 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.50e-04 | 212 | 44 | 4 | 33853758 | |
| Pubmed | 1.65e-04 | 653 | 44 | 6 | 22586326 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.65e-04 | 410 | 44 | 5 | 26949251 | |
| Pubmed | 1.80e-04 | 222 | 44 | 4 | 37071664 | ||
| Pubmed | 1.84e-04 | 1285 | 44 | 8 | 35914814 | ||
| Pubmed | 1.86e-04 | 16 | 44 | 2 | 10932191 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 1.89e-04 | 670 | 44 | 6 | 22990118 | |
| Pubmed | Chromatin boundaries require functional collaboration between the hSET1 and NURF complexes. | 2.10e-04 | 17 | 44 | 2 | 21653943 | |
| Pubmed | USF1 recruits histone modification complexes and is critical for maintenance of a chromatin barrier. | 2.36e-04 | 18 | 44 | 2 | 17846119 | |
| Pubmed | Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. | 2.36e-04 | 18 | 44 | 2 | 15829968 | |
| Pubmed | SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression. | 2.36e-04 | 18 | 44 | 2 | 29996942 | |
| Pubmed | 2.36e-04 | 18 | 44 | 2 | 9858769 | ||
| Pubmed | 2.44e-04 | 446 | 44 | 5 | 24255178 | ||
| Pubmed | 2.57e-04 | 709 | 44 | 6 | 22988430 | ||
| Pubmed | 2.62e-04 | 1014 | 44 | 7 | 32416067 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 2.78e-04 | 1024 | 44 | 7 | 24711643 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 3.02e-04 | 1038 | 44 | 7 | 26673895 | |
| Pubmed | 3.07e-04 | 469 | 44 | 5 | 27634302 | ||
| Pubmed | 3.16e-04 | 472 | 44 | 5 | 38943005 | ||
| Pubmed | 3.42e-04 | 263 | 44 | 4 | 34702444 | ||
| Pubmed | 3.56e-04 | 22 | 44 | 2 | 16751104 | ||
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 3.61e-04 | 109 | 44 | 3 | 33554859 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.51e-04 | 283 | 44 | 4 | 30585729 | |
| Pubmed | 4.67e-04 | 119 | 44 | 3 | 23508102 | ||
| Pubmed | 4.82e-04 | 288 | 44 | 4 | 23383273 | ||
| Pubmed | Molecular profiles of mitogen activated protein kinase signaling pathways in orofacial development. | 4.99e-04 | 26 | 44 | 2 | 17177285 | |
| Pubmed | 5.38e-04 | 27 | 44 | 2 | 20301402 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 5.50e-04 | 533 | 44 | 5 | 30554943 | |
| Pubmed | 5.79e-04 | 28 | 44 | 2 | 38324473 | ||
| Interaction | H2BC21 interactions | 1.55e-06 | 696 | 43 | 10 | int:H2BC21 | |
| Interaction | TERF2IP interactions | 2.00e-06 | 552 | 43 | 9 | int:TERF2IP | |
| Interaction | WWTR1 interactions | 2.64e-06 | 422 | 43 | 8 | int:WWTR1 | |
| Interaction | HNF1B interactions | 2.96e-06 | 190 | 43 | 6 | int:HNF1B | |
| Interaction | FOSB interactions | 3.55e-06 | 49 | 43 | 4 | int:FOSB | |
| Interaction | FEV interactions | 4.34e-06 | 203 | 43 | 6 | int:FEV | |
| Interaction | YY1 interactions | 4.53e-06 | 454 | 43 | 8 | int:YY1 | |
| Interaction | ETS1 interactions | 5.76e-06 | 121 | 43 | 5 | int:ETS1 | |
| Interaction | DUXB interactions | 7.22e-06 | 18 | 43 | 3 | int:DUXB | |
| Interaction | PAX6 interactions | 1.13e-05 | 366 | 43 | 7 | int:PAX6 | |
| Interaction | ASF1A interactions | 1.39e-05 | 249 | 43 | 6 | int:ASF1A | |
| Interaction | YWHAH interactions | MAP3K20 ZCCHC14 TAB2 HIVEP1 DST WNK1 MARCHF4 MAP4K4 TRIP11 CREBBP NSD3 | 1.42e-05 | 1102 | 43 | 11 | int:YWHAH |
| Interaction | FOSL1 interactions | 1.49e-05 | 70 | 43 | 4 | int:FOSL1 | |
| Interaction | FBXO42 interactions | 1.74e-05 | 259 | 43 | 6 | int:FBXO42 | |
| Interaction | HNF4A interactions | 2.44e-05 | 275 | 43 | 6 | int:HNF4A | |
| Interaction | ETV7 interactions | 2.55e-05 | 27 | 43 | 3 | int:ETV7 | |
| Interaction | INSYN1 interactions | 2.91e-05 | 169 | 43 | 5 | int:INSYN1 | |
| Interaction | EGR2 interactions | 3.08e-05 | 171 | 43 | 5 | int:EGR2 | |
| Interaction | PAX2 interactions | 3.21e-05 | 85 | 43 | 4 | int:PAX2 | |
| Interaction | NFYC interactions | 3.63e-05 | 177 | 43 | 5 | int:NFYC | |
| Interaction | NHLH1 interactions | 3.68e-05 | 88 | 43 | 4 | int:NHLH1 | |
| Interaction | APEX1 interactions | BPTF CFAP74 CHD7 POGZ HIVEP1 GTF3C1 EP400 ATF2 CIAO3 NSD3 ZNF280C | 5.31e-05 | 1271 | 43 | 11 | int:APEX1 |
| Interaction | MYOD1 interactions | 5.61e-05 | 194 | 43 | 5 | int:MYOD1 | |
| Interaction | KLF8 interactions | 6.63e-05 | 329 | 43 | 6 | int:KLF8 | |
| Interaction | POLR1G interactions | 7.17e-05 | 489 | 43 | 7 | int:POLR1G | |
| Interaction | PARP1 interactions | BPTF CHD7 POGZ HIVEP1 CDC5L GTF3C1 EP400 MAP4K4 CREBBP PDLIM7 NSD3 | 7.28e-05 | 1316 | 43 | 11 | int:PARP1 |
| Interaction | H3C3 interactions | 7.74e-05 | 495 | 43 | 7 | int:H3C3 | |
| Interaction | NFIC interactions | 8.17e-05 | 210 | 43 | 5 | int:NFIC | |
| Interaction | JDP2 interactions | 9.80e-05 | 42 | 43 | 3 | int:JDP2 | |
| Interaction | TBXT interactions | 1.08e-04 | 116 | 43 | 4 | int:TBXT | |
| Interaction | ERG interactions | 1.08e-04 | 223 | 43 | 5 | int:ERG | |
| Interaction | NFIX interactions | 1.18e-04 | 227 | 43 | 5 | int:NFIX | |
| Interaction | ELK3 interactions | 1.23e-04 | 120 | 43 | 4 | int:ELK3 | |
| Interaction | KDM1A interactions | 1.36e-04 | 941 | 43 | 9 | int:KDM1A | |
| Interaction | ELF1 interactions | 1.49e-04 | 126 | 43 | 4 | int:ELF1 | |
| Interaction | H3-3A interactions | 1.60e-04 | 749 | 43 | 8 | int:H3-3A | |
| Interaction | MYH9 interactions | 1.68e-04 | 754 | 43 | 8 | int:MYH9 | |
| Interaction | MYB interactions | 1.83e-04 | 133 | 43 | 4 | int:MYB | |
| Interaction | H2BC8 interactions | 1.98e-04 | 576 | 43 | 7 | int:H2BC8 | |
| Interaction | H2BC3 interactions | 2.09e-04 | 406 | 43 | 6 | int:H2BC3 | |
| Interaction | SUPT5H interactions | 2.15e-04 | 408 | 43 | 6 | int:SUPT5H | |
| Interaction | POU5F1 interactions | 2.15e-04 | 584 | 43 | 7 | int:POU5F1 | |
| Interaction | SRF interactions | 2.17e-04 | 139 | 43 | 4 | int:SRF | |
| Interaction | BRCA1 interactions | 2.36e-04 | 1249 | 43 | 10 | int:BRCA1 | |
| Interaction | ZMYM2 interactions | 2.69e-04 | 271 | 43 | 5 | int:ZMYM2 | |
| Interaction | DUXA interactions | 2.90e-04 | 12 | 43 | 2 | int:DUXA | |
| Interaction | SPATA12 interactions | 2.90e-04 | 12 | 43 | 2 | int:SPATA12 | |
| Interaction | MECP2 interactions | 3.00e-04 | 1287 | 43 | 10 | int:MECP2 | |
| Interaction | BAG2 interactions | 3.16e-04 | 622 | 43 | 7 | int:BAG2 | |
| Interaction | NUP43 interactions | 3.25e-04 | 625 | 43 | 7 | int:NUP43 | |
| Interaction | MAPK10 interactions | 3.29e-04 | 63 | 43 | 3 | int:MAPK10 | |
| Interaction | ELF2 interactions | 3.37e-04 | 156 | 43 | 4 | int:ELF2 | |
| Interaction | H3-4 interactions | 3.54e-04 | 448 | 43 | 6 | int:H3-4 | |
| Interaction | CBX3 interactions | 3.97e-04 | 646 | 43 | 7 | int:CBX3 | |
| Interaction | MACROH2A1 interactions | 3.99e-04 | 458 | 43 | 6 | int:MACROH2A1 | |
| Interaction | SMARCA4 interactions | 4.17e-04 | 462 | 43 | 6 | int:SMARCA4 | |
| Interaction | SP7 interactions | 4.55e-04 | 304 | 43 | 5 | int:SP7 | |
| Interaction | FOS interactions | 5.12e-04 | 312 | 43 | 5 | int:FOS | |
| Interaction | TLX1 interactions | 5.21e-04 | 175 | 43 | 4 | int:TLX1 | |
| Interaction | RBCK1 interactions | 5.32e-04 | 176 | 43 | 4 | int:RBCK1 | |
| Interaction | TEAD1 interactions | 5.32e-04 | 176 | 43 | 4 | int:TEAD1 | |
| Interaction | H3C1 interactions | 5.57e-04 | 901 | 43 | 8 | int:H3C1 | |
| Interaction | LITAF interactions | 5.93e-04 | 77 | 43 | 3 | int:LITAF | |
| Interaction | SFN interactions | 5.99e-04 | 692 | 43 | 7 | int:SFN | |
| Interaction | CRABP2 interactions | 6.16e-04 | 78 | 43 | 3 | int:CRABP2 | |
| Interaction | LHX2 interactions | 6.16e-04 | 183 | 43 | 4 | int:LHX2 | |
| Interaction | LHX3 interactions | 6.41e-04 | 185 | 43 | 4 | int:LHX3 | |
| Interaction | THRB interactions | 6.54e-04 | 186 | 43 | 4 | int:THRB | |
| Interaction | H2AC4 interactions | 6.74e-04 | 506 | 43 | 6 | int:H2AC4 | |
| Interaction | RBBP7 interactions | 6.81e-04 | 507 | 43 | 6 | int:RBBP7 | |
| Interaction | BRDT interactions | 6.87e-04 | 81 | 43 | 3 | int:BRDT | |
| Interaction | STAT2 interactions | 6.87e-04 | 81 | 43 | 3 | int:STAT2 | |
| Interaction | EED interactions | BPTF CHD7 POGZ CDC5L GTF3C1 EP400 PDLIM7 VPS13C UBR4 ZNF280C | 7.50e-04 | 1445 | 43 | 10 | int:EED |
| Interaction | CHD8 interactions | 7.51e-04 | 193 | 43 | 4 | int:CHD8 | |
| Interaction | KLF12 interactions | 7.66e-04 | 194 | 43 | 4 | int:KLF12 | |
| Interaction | KLF5 interactions | 7.81e-04 | 195 | 43 | 4 | int:KLF5 | |
| Interaction | USF1 interactions | 7.91e-04 | 85 | 43 | 3 | int:USF1 | |
| Interaction | PBX1 interactions | 7.91e-04 | 85 | 43 | 3 | int:PBX1 | |
| Interaction | ADGRA3 interactions | 8.25e-04 | 20 | 43 | 2 | int:ADGRA3 | |
| Interaction | POLR1E interactions | 8.60e-04 | 350 | 43 | 5 | int:POLR1E | |
| Interaction | NR3C1 interactions | 9.28e-04 | 974 | 43 | 8 | int:NR3C1 | |
| Interaction | PRR20B interactions | 9.34e-04 | 90 | 43 | 3 | int:PRR20B | |
| Interaction | PRR20C interactions | 9.34e-04 | 90 | 43 | 3 | int:PRR20C | |
| Interaction | PRR20D interactions | 9.34e-04 | 90 | 43 | 3 | int:PRR20D | |
| Interaction | TAL1 interactions | 1.03e-03 | 93 | 43 | 3 | int:TAL1 | |
| Interaction | AR interactions | 1.04e-03 | 992 | 43 | 8 | int:AR | |
| Interaction | COIL interactions | 1.06e-03 | 552 | 43 | 6 | int:COIL | |
| Interaction | ZMYND11 interactions | 1.06e-03 | 94 | 43 | 3 | int:ZMYND11 | |
| Interaction | CEBPA interactions | 1.06e-03 | 1245 | 43 | 9 | int:CEBPA | |
| Interaction | YWHAG interactions | 1.08e-03 | 1248 | 43 | 9 | int:YWHAG | |
| Interaction | MLLT6 interactions | 1.09e-03 | 95 | 43 | 3 | int:MLLT6 | |
| Interaction | SMC5 interactions | 1.10e-03 | 1000 | 43 | 8 | int:SMC5 | |
| Interaction | H2AZ1 interactions | 1.12e-03 | 371 | 43 | 5 | int:H2AZ1 | |
| Interaction | TRAF3IP1 interactions | 1.13e-03 | 96 | 43 | 3 | int:TRAF3IP1 | |
| Interaction | YWHAE interactions | 1.13e-03 | 1256 | 43 | 9 | int:YWHAE | |
| Interaction | SOX9 interactions | 1.16e-03 | 97 | 43 | 3 | int:SOX9 | |
| Interaction | HSPB7 interactions | 1.19e-03 | 24 | 43 | 2 | int:HSPB7 | |
| Interaction | CENPA interactions | 1.20e-03 | 377 | 43 | 5 | int:CENPA | |
| Interaction | TFCP2L1 interactions | 1.23e-03 | 99 | 43 | 3 | int:TFCP2L1 | |
| Interaction | ANKRD10 interactions | 1.29e-03 | 25 | 43 | 2 | int:ANKRD10 | |
| Cytoband | 2q11.2-q12 | 8.98e-07 | 2 | 44 | 2 | 2q11.2-q12 | |
| Cytoband | 16p13.3 | 8.94e-05 | 244 | 44 | 4 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 7.40e-04 | 426 | 44 | 4 | chr16p13 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.46e-04 | 53 | 35 | 3 | 532 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.68e-08 | 180 | 43 | 7 | M8239 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 2.35e-08 | 189 | 43 | 7 | M3112 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 9.13e-06 | 300 | 43 | 6 | M8702 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 9.95e-06 | 466 | 43 | 7 | M13522 | |
| Coexpression | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER | 1.72e-05 | 94 | 43 | 4 | M18108 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | 1.87e-05 | 946 | 43 | 9 | M39169 | |
| Coexpression | EIF4E_DN | 2.20e-05 | 100 | 43 | 4 | M2790 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 4.95e-05 | 822 | 43 | 8 | M6782 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 6.59e-05 | 856 | 43 | 8 | M4500 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | 2.05e-04 | 1009 | 43 | 8 | M157 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | 2.06e-04 | 526 | 43 | 6 | M2520 | |
| Coexpression | GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN | 3.10e-04 | 198 | 43 | 4 | M5307 | |
| Coexpression | GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP | 3.16e-04 | 199 | 43 | 4 | M9238 | |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN | 3.16e-04 | 199 | 43 | 4 | M6157 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 3.22e-04 | 200 | 43 | 4 | M5063 | |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP | 3.22e-04 | 200 | 43 | 4 | M7776 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN | 3.22e-04 | 200 | 43 | 4 | M8040 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP | 3.22e-04 | 200 | 43 | 4 | M8042 | |
| Coexpression | GSE27786_LIN_NEG_VS_CD4_TCELL_DN | 3.22e-04 | 200 | 43 | 4 | M4773 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-06 | 184 | 44 | 5 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.34e-06 | 194 | 44 | 5 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.52e-06 | 199 | 44 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.52e-06 | 199 | 44 | 5 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.52e-06 | 199 | 44 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Severe-B_naive-11|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.92e-05 | 161 | 44 | 4 | ad3b58e3a8b59a609c8d2d2690d15218d18eabbd | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 175 | 44 | 4 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 3.17e-05 | 183 | 44 | 4 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-05 | 185 | 44 | 4 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.37e-05 | 186 | 44 | 4 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.82e-05 | 192 | 44 | 4 | ef86d82e4f04f9f54e821ef496d70fc81072d773 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.90e-05 | 193 | 44 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | control-Myeloid-Neutrophils_3|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.90e-05 | 193 | 44 | 4 | 56daf3c59a124dd068af5409113913d9ee81a454 | |
| ToppCell | Monocytes-cDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.22e-05 | 197 | 44 | 4 | 3388c104af4c6a05988e102627e0c5e34d9dcc45 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.30e-05 | 198 | 44 | 4 | c8272ac4d90f2367f538f66db40de911ad73ea7f | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 4.39e-05 | 199 | 44 | 4 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 4.39e-05 | 199 | 44 | 4 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 4.39e-05 | 199 | 44 | 4 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.39e-05 | 199 | 44 | 4 | 8d13a9ea87f685b5a34b84c4571db6be753cf2d9 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 4.39e-05 | 199 | 44 | 4 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.39e-05 | 199 | 44 | 4 | 9940f347973bf976ee23fb4b1cf1f349d96c21df | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.93e-04 | 131 | 44 | 3 | 2ccf679b5035b7b9cdb9a9a660cad90288592187 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.93e-04 | 131 | 44 | 3 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-04 | 137 | 44 | 3 | 85b3a98039c1f68addad0334aa5b2584f6045aaa | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.78e-04 | 143 | 44 | 3 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 4.18e-04 | 148 | 44 | 3 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.88e-04 | 156 | 44 | 3 | 0b3630fd4479291599e1674e87eba6f93877ac3a | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.25e-04 | 160 | 44 | 3 | 7ad065337ac802de52c15ee715f6b78a3eed0cef | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 5.45e-04 | 162 | 44 | 3 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.74e-04 | 165 | 44 | 3 | 3d14f37b8a9c0ddc1130e60a2e08556bad1fb855 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.74e-04 | 165 | 44 | 3 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|COVID-19_Mild / Disease condition and Cell class | 5.74e-04 | 165 | 44 | 3 | ef709c5d3231c65d351316e1e31b9c9eba721628 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.85e-04 | 166 | 44 | 3 | a907d39ca5cf023de633fe5f2b28759b7af4eebc | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 167 | 44 | 3 | 3c4183a8225bae37b9f5341ebd1b95409ced2022 | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 167 | 44 | 3 | 28e9670586ff551b700c794313d27eedbfa1286b | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.05e-04 | 168 | 44 | 3 | af82e07d1eec51fc6530155f37addbce6221885d | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 6.05e-04 | 168 | 44 | 3 | d50078614f7af74dc2aa4081c1708a5156ac51cf | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.16e-04 | 169 | 44 | 3 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.16e-04 | 169 | 44 | 3 | 1c9e54e7b14eb99996590fb93b257cf881a9f184 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.26e-04 | 170 | 44 | 3 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | Severe-B_naive-11|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.37e-04 | 171 | 44 | 3 | 7c2699f19ca38414447a286f7658f507882d57c2 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.48e-04 | 172 | 44 | 3 | bc3ed05fdd94d5e1f19285aea867b1453292baec | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-04 | 173 | 44 | 3 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | Frontal_cortex-Macroglia|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.59e-04 | 173 | 44 | 3 | ac70145e093ef0df43811e7c67a865ccdd45a5e3 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-04 | 173 | 44 | 3 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-04 | 173 | 44 | 3 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 6.70e-04 | 174 | 44 | 3 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.70e-04 | 174 | 44 | 3 | 412ccc099028a372b9d953363984c2da54b2187f | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.93e-04 | 176 | 44 | 3 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.93e-04 | 176 | 44 | 3 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.04e-04 | 177 | 44 | 3 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | Globus_pallidus-Macroglia|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.27e-04 | 179 | 44 | 3 | ab50f711b004b96107f813c9a2526ec21d1c8027 | |
| ToppCell | Entopeduncular-Macroglia|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.27e-04 | 179 | 44 | 3 | f61974710a60aa0618fdb30d864fb9bc7c05ef21 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.39e-04 | 180 | 44 | 3 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-04 | 181 | 44 | 3 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.51e-04 | 181 | 44 | 3 | a436e7e4c36403257ea90160a58ca0d6d7c0cdfc | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|COVID-19_Severe / Disease condition and Cell class | 7.51e-04 | 181 | 44 | 3 | 0d07a67e8ee3bca687b378afbc4044434e63556d | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.51e-04 | 181 | 44 | 3 | d66838fca0429cad2079cd8d92a5cd33eb0d3522 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.51e-04 | 181 | 44 | 3 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 7.63e-04 | 182 | 44 | 3 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.63e-04 | 182 | 44 | 3 | ecb5624c9074cc6449fad961df54c926c2681d54 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.75e-04 | 183 | 44 | 3 | 547b1fb9f9940cfc8d6e351d96acc0da44def57e | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.75e-04 | 183 | 44 | 3 | d67454baf0cf791a743b51afd1cb25bfb5765385 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.75e-04 | 183 | 44 | 3 | e84539978ab4de42e19186aed00f24bb50cbc21f | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.75e-04 | 183 | 44 | 3 | e49ac8314b6fe98426b1514ea68d646297b8bc0f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.88e-04 | 184 | 44 | 3 | 7b5678718719020b52e7c2a7bd9797987defd7ff | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 7.88e-04 | 184 | 44 | 3 | d97471a4fe17cba6880ccf1a04cc00c741558124 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.88e-04 | 184 | 44 | 3 | 226ccac00ac1c3a0ad7283785fd14312320e0ca6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.88e-04 | 184 | 44 | 3 | 54e5b63f55b8d6eccad53d389ea9c78f991e1414 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 8.00e-04 | 185 | 44 | 3 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 8.00e-04 | 185 | 44 | 3 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-Naive_B_cells|GI_large-bowel / Manually curated celltypes from each tissue | 8.00e-04 | 185 | 44 | 3 | 1c99373c123b5e0de40b47d9d885974a747b9839 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-04 | 185 | 44 | 3 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.13e-04 | 186 | 44 | 3 | 1a1e5d85a5ad90afee234c12a9b54a5e93a8a2f2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.13e-04 | 186 | 44 | 3 | f1366638edaecad5cad6367440f4c693513bed7e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.13e-04 | 186 | 44 | 3 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.25e-04 | 187 | 44 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.38e-04 | 188 | 44 | 3 | d1bc1316bbb8cfc39acc70f8680b14d19f536997 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-04 | 188 | 44 | 3 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.38e-04 | 188 | 44 | 3 | ccd2541892112a7a303f766adf9a7afeb754498c | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 8.51e-04 | 189 | 44 | 3 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 8.51e-04 | 189 | 44 | 3 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-04 | 189 | 44 | 3 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-04 | 189 | 44 | 3 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 8.51e-04 | 189 | 44 | 3 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-04 | 189 | 44 | 3 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.64e-04 | 190 | 44 | 3 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.64e-04 | 190 | 44 | 3 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.64e-04 | 190 | 44 | 3 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.64e-04 | 190 | 44 | 3 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.64e-04 | 190 | 44 | 3 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.64e-04 | 190 | 44 | 3 | 71a00f63fdd4eb4cc6f190d37e7a0417cdaafacb | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 8.64e-04 | 190 | 44 | 3 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.64e-04 | 190 | 44 | 3 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-04 | 191 | 44 | 3 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-04 | 191 | 44 | 3 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.77e-04 | 191 | 44 | 3 | a073d58154c801ec499fd969f42b7f1ee7f15d79 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.77e-04 | 191 | 44 | 3 | b9b091d6b352d5128bb864ff52d2e5fb3387b766 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-04 | 191 | 44 | 3 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-04 | 191 | 44 | 3 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.56e-04 | 50 | 27 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | Cefotetan [69712-56-7]; Up 200; 7uM; HL60; HT_HG-U133A | 1.57e-06 | 197 | 42 | 6 | 1319_UP | |
| Drug | Picotamide monohydrate [80530-63-8]; Up 200; 10.2uM; HL60; HG-U133A | 1.72e-06 | 200 | 42 | 6 | 1387_UP | |
| Drug | Anisomycin | 1.90e-05 | 86 | 42 | 4 | ctd:D000841 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.12e-05 | 183 | 42 | 5 | 7136_DN | |
| Drug | Convolamine hydrochloride [500-56-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.61e-05 | 191 | 42 | 5 | 2771_UP | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; PC3; HT_HG-U133A | 2.74e-05 | 193 | 42 | 5 | 6760_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Up 200; 17uM; PC3; HT_HG-U133A | 2.81e-05 | 194 | 42 | 5 | 4538_UP | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.88e-05 | 195 | 42 | 5 | 5444_UP | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; PC3; HT_HG-U133A | 2.95e-05 | 196 | 42 | 5 | 3685_DN | |
| Drug | Etodolac [41340-25-4]; Up 200; 14uM; HL60; HG-U133A | 3.10e-05 | 198 | 42 | 5 | 1407_UP | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.50e-05 | 152 | 42 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 2.10e-04 | 206 | 42 | 4 | C0152013 | |
| Disease | eosinophil percentage of granulocytes | 3.41e-04 | 234 | 42 | 4 | EFO_0007996 | |
| Disease | diabetic retinopathy | 9.64e-04 | 136 | 42 | 3 | EFO_0003770 | |
| Disease | red blood cell density measurement | 1.45e-03 | 880 | 42 | 6 | EFO_0007978 | |
| Disease | vital capacity | 1.66e-03 | 1236 | 42 | 7 | EFO_0004312 | |
| Disease | neutrophil-to-lymphocyte ratio | 2.33e-03 | 185 | 42 | 3 | EFO_0008447 | |
| Disease | Huntington's disease (is_marker_for) | 2.60e-03 | 53 | 42 | 2 | DOID:12858 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AVVQQPNCRTSVPSS | 396 | P51826 | |
| TTNLTPVQTPARSLV | 2716 | Q96L91 | |
| VVQTPNTVLSTPFRT | 401 | Q99459 | |
| KTAIRIPTSNPQTSN | 966 | Q8IVF6 | |
| VARNAATITVTPPQS | 86 | Q6PL45 | |
| ATSLSNQVRSPAPVQ | 2336 | Q92793 | |
| RPQSLQQPATSTTET | 311 | P15336 | |
| SFQPRTATVTIRPNT | 2151 | Q12830 | |
| QDVVTPNSVRSQVPA | 301 | Q8N7E2 | |
| NFSSRSQTVPSPTIN | 291 | Q9P2D1 | |
| SSVITQAPSTNRQIG | 141 | Q02930 | |
| VVNVNPTNTRPQSDT | 901 | O95819 | |
| QAAQAASPQVPATTT | 7426 | Q03001 | |
| TTPNAQATRSTPVSR | 321 | P08174 | |
| PRTPNRSVSSNVASV | 406 | Q9Y6G9 | |
| VPLSTTPRSNASVNV | 131 | Q9HCN3 | |
| TPTPLQSRTSIVQAA | 251 | Q9NR12 | |
| SSSTEQIRATTPPNQ | 221 | Q8IWW6 | |
| TVPQTLRPQTATNSN | 86 | O43825 | |
| PSSPRNVISNINETS | 326 | P29320 | |
| QITPVNQSRSSSPTQ | 626 | Q9NYL2 | |
| RTNPRTSSSTQANIP | 331 | Q9P2E8 | |
| QFQQSPKPARSVTTS | 91 | P50461 | |
| LSSPSQRTEVVGTQN | 1401 | Q9C0B2 | |
| AVSQNSRISPPVSTS | 21 | Q6ZUA9 | |
| NSATSPRVVVTQPNT | 446 | Q9NYJ8 | |
| IPATLTIRSTVPQSQ | 231 | Q7Z3K3 | |
| QETPQSRPSVQVVSA | 36 | O15457 | |
| NRTVTQPPLSTVQLT | 331 | A0A1B0GV85 | |
| PSQQRLVVVSVSPQS | 106 | Q9H6Q4 | |
| QLTSSTLTNPRQSPV | 41 | Q01959 | |
| SQPSPTQSVQETVRV | 1891 | Q709C8 | |
| ASFIPQVTQPSATRT | 2081 | Q68DE3 | |
| STPNQRNEKPTQSVS | 546 | Q9BZ95 | |
| TVQSKTAPPTFNRTN | 356 | Q9HBG4 | |
| TSSSARPTAQVLPVQ | 466 | Q8WYQ9 | |
| FSQSSQLTPPQQTRV | 631 | Q9BRH9 | |
| TPLRPNQQSVVNSSF | 1846 | Q15643 | |
| FLQVTPPTSQNTTAR | 536 | Q8ND82 | |
| TATATSQVAQQPPAA | 126 | Q9H4A3 | |
| NSSTANRVKTSQPPV | 716 | Q12789 | |
| QLTSVFNPRTVASQP | 196 | Q5T4S7 | |
| FNPRTVASQPISTQT | 201 | Q5T4S7 | |
| VTSATAPNPVRNLTV | 291 | Q9HD43 | |
| LTSPSSRSQVTPQNQ | 336 | P15822 |